China's Biggest Memory Chip Stock Is Almost as Good as Micron

ChangXin Memory Technologies (CXMT) IPO’d on Shanghai, raising $8.6B and briefly flashing a ~466% first-day run-up to a ~$487B market cap, but the bigger implication is competitive pressure on Micron. In H1 2026, CXMT grew revenue +874% YoY to 150.3B yuan ($22.4B) and posted net profit of 77.6B yuan ($11.5B) with a 51.6% margin, implying a fast-closing profitability gap vs Micron’s 63%. Beginning end-2026 CXMT will produce stacked DRAM for HBM (key for AI), and CXMT’s DRAM market share is cited at 11% vs Micron’s 25% with an estimated path to 15% by 2030—supportive for CXMT but a margin-risk signal for Micron (MU shares fell 9% on IPO day and another 10% the next day).

Analysis

Near term, the relevant risk is not CXMT taking HBM share tomorrow; it is a pricing umbrella over the entire DRAM stack. When a subsidized producer scales rapidly, the first-order effect is channel discipline breaking in commodity and mobile DRAM, which can pull down global ASPs before any technology catch-up is visible in AI memory.

For MU, that matters because the market prices memory on forward peak margins, not current shipments. If low-end DRAM weakens, MU can still post good revenue, but gross margin leverage gets capped and the stock’s multiple can de-rate even if HBM stays tight. Relative winners are AI system integrators and hyperscalers: cheaper memory lowers total server BOM, which can support NVDA demand and accelerate capex budgets even as memory suppliers take the margin hit.

The structural 6-18 month issue is Chinese domestic substitution. Once customers qualify a homegrown source, procurement becomes less about cost-plus economics and more about supply assurance, which can erode bargaining power for Micron and, later, SK hynix. The contrarian mistake is to focus only on CXMT’s technology lag; the bear case is really about overcapacity and price competition long before CXMT closes the HBM gap. Falsifiers: MU maintaining DRAM ASPs and HBM mix through the next two earnings calls, or CXMT hitting manufacturing/qualification delays that slow share gains.

Key Decisions for Investors

• Short MU on strength or use 3-6 month put spreads into the next earnings cycle; thesis works if DRAM ASPs roll over and guide cuts begin to reflect mix pressure.
• Pair trade: long NVDA / short MU for the next 1-3 quarters. Memory deflation helps AI system economics while MU is more exposed to margin compression than accelerator vendors.
• Relative-value long SKHY vs. short MU if you want a cleaner hedge on HBM leadership; exit if MU continues to report stable HBM pricing and SKHY commentary suggests China share loss is contained.
• If MU is down sharply before the next print and management raises full-year HBM supply or margin guide, cover the short: that would imply the market already discounted the near-term share threat.